Collagen Type I antibody
Quick Overview for Collagen Type I antibody (ABIN372599)
Target
See all Collagen Type I (COL1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- Specific for the ~180 kDa Collagen I Alpha-1 Propeptide in Human lung fibroblast extract.
-
Cross-Reactivity (Details)
-
Species reactivity (expected):most (if not all) Species of Mammals, Birds, Amphibians and Fishes.
Species reactivity (tested):Human and Mouse. -
Purification
- Affinity Chromatography.
-
Immunogen
- Peptide from the Human Collagen I Alpha-1 propeptide sequence.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Western Blot: 1/1000. Immunohistochemitry: 1/100. The antibody also works well for Immunohistochemistry on Paraformaldehyde-FixedSections with a simple antigen-retrieval protocol (incubate slides for 20 minutes at 90 °C in10 mM sodium citrate ( pH 6.0)/ 0.1 % Tween-20). Note that in Paraffin Sections of Formaldehyde-Fixed fibrotic mouse lung tissue, itrecognizes collagen I molecules that are still associated with the cells in which they weresynthesized.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS. Contains no preservative
-
Preservative
- Without preservative
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store the antibody undiluted (in aliquots) at-20 °C.
-
-
-
Effects of chronically increased VEGF-A on the aging heart." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 32, Issue 3, pp. 1550-1565, (2018) (PubMed).
: "In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets." in: International journal of molecular sciences, Vol. 19, Issue 4, (2018) (PubMed).
: "Hypoxia Inducible Factors Modify Collagen I Fibers in MDA-MB-231 Triple Negative Breast Cancer Xenografts." in: Neoplasia (New York, N.Y.), Vol. 20, Issue 2, pp. 131-139, (2018) (PubMed).
: "
-
Effects of chronically increased VEGF-A on the aging heart." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 32, Issue 3, pp. 1550-1565, (2018) (PubMed).
-
- Collagen Type I (COL1) (Collagen, Type I (COL1))
-
Alternative Name
- Collagen Type I
-
Background
- Collagen is the most abundant protein in mammals with type 1 collagen being the most abundant of the 29 known collagens. Type 1 collagen is integral in the strengthening and structural support of many tissues including skin, tendon, artery walls, fibrocartilage, bone and teeth. Collagens are synthesized with N-terminal and C-terminal propeptides that are cleaved during maturation and secretion. After cleavage of the propeptides, the most N-terminal and C-terminal remaining sequences are known as telopeptides. Mutations in the collagen 1, alpha 1 gene (COL1A1) are known to cause osteogenesis imperfecta (aka brittle bone disease) (Byers 1989). Furthermore, mutations found in the fist 90 residues of the helical region of alpha 1 collagen have been implicated in the prevention or delayed removal of the procoallagen N-propeptide leading to a combined osteogenesis imperfecta and Ehlers-Danlos syndrome (EDS) phenotype (Cabral et al., 2005).Synonyms: Alpha-1 type I collagen, Alpha-2 type I collagen, COL1A1, COL1A2
-
Gene ID
- 1277
-
NCBI Accession
- NP_000079
-
UniProt
- P02452
Target
-